Holen Sie sich die Stockscreener-App
28.29
1.67%
-0.48
Handel nachbörslich:
28.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLP?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Simulations Plus Inc Aktie (SLP) Neueste Nachrichten
Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of “Buy” by Brokerages - Defense World
Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by Royce & Associates LP - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Simulations Plus (NASDAQ:SLP) Upgraded at Stephens - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by US Bancorp DE - Defense World
Stephens Initiates Coverage on Simulations Plus (NASDAQ:SLP) - MarketBeat
Where are the Opportunities in (SLP) - Stock Traders Daily
Simulations Plus Inc (SLP) Shares Gap Down to $30.515 on Nov 14 - GuruFocus.com
Simulations Plus Wins FDA Grant for Revolutionary Drug Delivery Modeling Technology | SLP Stock News - StockTitan
Biosimulation Market on Track for Strong Growth by 2031 | Certara, Simulations Plus Inc, Rhenovia Pharma - openPR
William Blair Issues Positive Forecast for SLP Earnings - Defense World
How Much Upside is Left in Simulations Plus (SLP)? Wall Street Analysts Think 77.52% - Yahoo Finance
William Blair Boosts Earnings Estimates for Simulations Plus - MarketBeat
We Think Simulations Plus' (NASDAQ:SLP) Healthy Earnings Might Be Conservative - Simply Wall St
Q1 EPS Forecast for Simulations Plus Raised by Analyst - MarketBeat
We Think Simulations Plus' (NASDAQ:SLP) Solid Earnings Are Understated - Yahoo Finance
Simulations Plus CEO to Present at Stephens Investment Conference | Key Biotech Insights | SLP Stock News - StockTitan
Simulations Plus (NASDAQ:SLP) Given "Outperform" Rating at William Blair - MarketBeat
StockNews.com Downgrades Simulations Plus (NASDAQ:SLP) to Sell - Defense World
Insider Sale: Director and 10% Owner Walter Woltosz Sells 20,000 Shares of Simulations Plus Inc (SLP) - GuruFocus.com
Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $553,200.00 in Stock - MarketBeat
Simulations Plus director Walter Woltosz sells $553,200 in stock - Investing.com
Simulations Plus director Walter Woltosz sells $553,200 in stock By Investing.com - Investing.com UK
Simulations Plus (NASDAQ:SLP) Stock Rating Lowered by StockNews.com - MarketBeat
Conestoga Capital Advisors LLC Trims Stock Position in Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Simulations Plus Halts Dividends to Boost Long-Term Growth: What It Means for Investors - Nasdaq
Simulations Plus secures FDA grant for drug testing tech By Investing.com - Investing.com Canada
Simulations Plus (NASDAQ:SLP) Sets New 12-Month LowTime to Sell? - MarketBeat
Simulations Plus stock hits 52-week low at $29.32 amid market shifts - Investing.com
Simulations Plus secures FDA grant for drug testing tech - Investing.com
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations - The Bakersfield Californian
Biosimulation Market is expected to Double Its Size by Upcoming - openPR
Tributary Capital Management LLC Buys 115,122 Shares of Simulations Plus, Inc. (NASDAQ:SLP) - MarketBeat
Q2 Earnings Forecast for SLP Issued By William Blair - Defense World
Brokers Offer Predictions for SLP Q2 Earnings - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives $56.00 Consensus Price Target from Analysts - Defense World
Simulations Plus' Q4 Earnings Top Estimates on Solid Revenue Growth - MSN
Simulations Plus (NASDAQ:SLP) Posts Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Simulations Plus Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles - Investing.com India
BTIG cuts Simulations Plus stock price target By Investing.com - Investing.com Australia
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M - MSN
Simulations Plus (NASDAQ:SLP) Receives "Outperform" Rating from William Blair - MarketBeat
Simulations Plus's SWOT analysis: biosimulation leader faces valuation hurdles By Investing.com - Investing.com UK
How To Trade (SLP) - Stock Traders Daily
Simulations Plus (NASDAQ:SLP) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Simulations Plus (NASDAQ:SLP) Price Target Cut to $50.00 by Analysts at BTIG Research - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Simulations Plus, Inc. (NASDAQ:SLP) Q4 2024 Earnings Call Transcript - Insider Monkey
BTIG cuts Simulations Plus stock price target - Investing.com
Simulations Plus price target lowered to $50 from $60 at BTIG - Nasdaq
Earnings call: Simulations Plus reports robust FY 2024 results, optimistic FY 2025 - Investing.com
Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market ... - Yahoo Finance
Simulations Plus Inc (SLP) Q4 2024 Earnings Call Highlights: Str - GuruFocus.com
0.40%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):